dc.contributor.author | Kazis, DA | en |
dc.contributor.author | Kimiskidis, VK | en |
dc.contributor.author | Papagiannopoulos, S | en |
dc.contributor.author | Sotirakoglou, K | en |
dc.contributor.author | Divanoglou, D | en |
dc.contributor.author | Vlaikidis, N | en |
dc.contributor.author | Mills, KR | en |
dc.contributor.author | Kazis, A | en |
dc.date.accessioned | 2014-06-06T06:47:15Z | |
dc.date.available | 2014-06-06T06:47:15Z | |
dc.date.issued | 2006 | en |
dc.identifier.issn | 12949361 | en |
dc.identifier.uri | http://62.217.125.90/xmlui/handle/123456789/3490 | |
dc.relation.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-33745758760&partnerID=40&md5=463331d95fb04f9395d7308fceb5ce93 | en |
dc.subject | Corticomotor threshold | en |
dc.subject | Silent period | en |
dc.subject | Transcranial magnetic stimulation | en |
dc.subject | Valproate | en |
dc.subject.other | valproic acid | en |
dc.subject.other | adolescent | en |
dc.subject.other | adult | en |
dc.subject.other | article | en |
dc.subject.other | clinical article | en |
dc.subject.other | controlled study | en |
dc.subject.other | evoked muscle response | en |
dc.subject.other | female | en |
dc.subject.other | generalized epilepsy | en |
dc.subject.other | human | en |
dc.subject.other | idiopathic disease | en |
dc.subject.other | nerve excitability | en |
dc.subject.other | priority journal | en |
dc.subject.other | stimulus response | en |
dc.subject.other | transcranial magnetic stimulation | en |
dc.subject.other | Adolescent | en |
dc.subject.other | Adult | en |
dc.subject.other | Anticonvulsants | en |
dc.subject.other | Dose-Response Relationship, Drug | en |
dc.subject.other | Epilepsy, Generalized | en |
dc.subject.other | Evoked Potentials, Motor | en |
dc.subject.other | Female | en |
dc.subject.other | Follow-Up Studies | en |
dc.subject.other | Humans | en |
dc.subject.other | Male | en |
dc.subject.other | Motor Cortex | en |
dc.subject.other | Transcranial Magnetic Stimulation | en |
dc.subject.other | Valproic Acid | en |
dc.title | The effect of valproate on silent period and corticomotor excitability | en |
heal.type | journalArticle | en |
heal.publicationDate | 2006 | en |
heal.abstract | Objective. To investigate, by transcranial magnetic stimulation, the effects of valproate on silent period and corticomotor excitability. Methods: thirty patients with generalized epilepsy were studied at baseline, and re-examined 4 (S1) and 25 (S2) weeks after the administration of valproate (mean dose: 1040 ± 284 mg). Transcranial magnetic stimulation was performed with a figure of eight coil (recording, first dorsal interosseous). Threshold was measured at 1% steps. Silent period was measured using a recently described protocol. Briefly, silent periods were elicited at 5% increments from 0 to 100% maximum stimulus intensity. At each stimulus intensity, 4 silent periods were obtained and the average value of silent period duration was used to construct a stimulus/response curve of stimulus intensity versus silent period. The resulting curves were then fitted to a Boltzman function and were statistically compared. The motor-evoked potential recruitment curve was constructed under active conditions and analyzed in a similar way. Results. Valproate increased threshold from 36.5 ± 5.99% at baseline to 41.02 ± 7.84% at S1 (p < 0.0001, paired t-test). The maximum value of the silent period curve decreased from 257.5 ± 3.9 ms at baseline to 230.3 ± 3.9 ms at S1 (p < 0.0001, F-test and AIC) while the other best-fit values (V50, slope, threshold) were not significantly affected. Regarding the motor-evoked potential recruitment curve, the maximum value decreased significantly post-drug (from 0.449 ± 0.007 to 0.392 ± 0.009, p < 0.01, F-test and AIC test), whereas the rest of the best-fit values remained unaffected. Conclusion. In patients with idiopathic generalized epilepsy, valproate increases threshold and reduces the maximum values of the silent period curve and the motor-evoked potential recruitment curve. These findings probably reflect valproate's effects on voltage-dependent Na+ channels, as well as an activation of GABAA receptors. | en |
heal.journalName | Epileptic Disorders | en |
dc.identifier.issue | 2 | en |
dc.identifier.volume | 8 | en |
dc.identifier.spage | 136 | en |
dc.identifier.epage | 142 | en |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |